Category > Discover Digital Health Startups in Clinical Trial Design

Discover Digital Health Startups in Clinical Trial Design

As of August 2026, the Clinical Trial Design category has a total of 45 Digital Health firms. The total venture volume has expanded at a CAGR of 14.4% over the past 5 years. The ventures have an average venture maturity score of 201.4.

From a funding perspective, these Digital Health companies have successfully raised $550.86M in venture capital investments, channeled through 60 distinct funding rounds. In the past 12 months, total venture capital funding closed at $202.35M across 10 deals.

Last Updated: August 29, 2026

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
H1	Clinical Trial Design	United States	xyrsttzsas	$ 123.46 B	Strategic	$ 40.00 M
PhaseV(פאזה וי ניסויים בע~מ)	Clinical Trial Design	Israel	xyrsttzsas	$ 123.46 B	Series A	$ 50.00 M
Novadiscovery	Clinical Trial Design	France	xyrsttzsas	$ 123.46 B	Series A1	$ 2.83 M
Iterative Health	Clinical Trial Design	United States	xyrsttzsas	$ 123.46 B	Series C	$ 77.00 M
Phesi	Clinical Trial Design	United States	xyrsttzsas	$ 123.46 B	Series A	$ 10.00 M
Peer AI	Clinical Trial Design	United States	xyrsttzsas	$ 123.46 B	Series A	$ 12.10 M
Biorce	Clinical Trial Design	Spain	xyrsttzsas	$ 123.46 B	Series A	$ 52.50 M
FindMeCure	Clinical Trial Design	United Kingdom	xyrsttzsas	$ 123.46 B	Seed	undisclosed
Intelligencia	Clinical Trial Design	Greece	xyrsttzsas	$ 123.46 B	Series A	$ 11.91 M
Giles	Clinical Trial Design	United Kingdom	xyrsttzsas	$ 123.46 B

Showing 1 to 10 of 45 entries